Jefferies maintained a Buy rating on Alnylam Pharmaceuticals (NASDAQ: ALNY), and cut the price target to $119.00 (from $122.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

Leerink Cuts Alnylam (ALNY) PT to $107May 3, 2016 8:14 AM Alnylam Pharma (ALNY) Misses Q1 EPS by 16cMay 2, 2016 4:03 PM Alnylam Pharmaceuticals Reports First Quarter 2016 Financial Results and Highlights Recent Period ProgressMay 2, 2016 4:00 PM Trading Radar for 5/2: AIG (AIG), Ferrari (RACE), Loews (L), On Deck Capital (ONDK), Tenet Healthcare (THC) ReportApril 29, 2016 3:24 PM